Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

Shenzhen Hepalink Pharmaceutical Group's P/E remains high de...

Shenzhen Hepalink Pharmaceutical Group's P/E remains high despite price drop, justified by superior earnings outlook. Investors see low risk of earnings deterioration, providing strong share price support.
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates. Read more
1
+0
Translate
Report
2734 Views
Comment
Sign in to post a comment